Azienda Ospedaliera San Gerardo di Monza
Quick facts
Marketed products
- Immediate switch to TDF/FTC/RPV · Infectious Disease / Virology
A fixed-dose combination of three antiretroviral agents that inhibits HIV reverse transcriptase and integrase to suppress viral replication. - Switch to TDF/FTC/RPV after 24 weeks · Infectious Disease / Virology
A combination antiretroviral regimen that suppresses HIV replication by inhibiting reverse transcriptase and integrase through three complementary agents.
Phase 3 pipeline
- Propofol + Remifentanyl · Anesthesiology
Propofol and remifentanil together provide rapid-onset sedation and analgesia by depressing the central nervous system through GABA potentiation and opioid receptor agonism, respectively. - Sevoflurane + Fentanyl · Anesthesiology
Sevoflurane is a volatile anesthetic that depresses central nervous system activity, while fentanyl is an opioid analgesic that binds to mu-opioid receptors to provide analgesia and sedation. - Sevoflurane + Remifentanyl · Anesthesiology
Sevoflurane is a general anesthetic that induces unconsciousness and amnesia, while Remifentanil is a potent opioid analgesic that provides pain relief.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Azienda Ospedaliera San Gerardo di Monza portfolio CI brief
- Azienda Ospedaliera San Gerardo di Monza pipeline updates RSS
Frequently asked questions about Azienda Ospedaliera San Gerardo di Monza
What are Azienda Ospedaliera San Gerardo di Monza's marketed drugs?
Top marketed products include Immediate switch to TDF/FTC/RPV, Switch to TDF/FTC/RPV after 24 weeks.
What is Azienda Ospedaliera San Gerardo di Monza's pipeline?
Azienda Ospedaliera San Gerardo di Monza has 3 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Propofol + Remifentanyl, Sevoflurane + Fentanyl, Sevoflurane + Remifentanyl.
Related
- Immediate switch to TDF/FTC/RPV · Infectious Disease / Virology
- Switch to TDF/FTC/RPV after 24 weeks · Infectious Disease / Virology
- Sector hub: All tracked pharma companies